Celerion has the experience and capacity to exceed your bioanalytical expectations from method development and validation through rapid sample analysis supporting discovery through late stage clinical trials.
Celerion’s facility in Zürich, Switzerland, is one of the most established laboratories in the industry, with over 25 years of bioanalytical operations experience. The team has the scientific expertise to analyze small and large molecules using the latest technologies and to ensure delivery of quality results on time.
The Celerion team has a strong background in both small and large molecule analysis, thereby offering the flexibility to fulfill client needs. This cross-functional experience translates to faster turnaround times and allows us to develop and validate the right assay to meet clinical and regulatory requirements.
Celerion provides full GLP-certified services in method validation and sample analysis using LC-MS/MS, ELISA, ECL, Western blot, RIA and other technologies.
With one of the largest ligand binding laboratories in Europe, and having more than 25 years experience in immunogenicity testing, the Zürich laboratory is renowned for experience with a wide variety of products, including therapeutic proteins (pegylated or non-pegylated), peptides and antibodies.
Excellent technical expertise, coupled with extensive experience in small and large molecules as well as biomarkers, ensures the delivery of high-quality data in a timely manner.
Global SOPs and a harmonized electronic laboratory notebook system enable easy assay transfer between the Celerion bioanalytical laboratories in Europe and North America and ensure compliance with internal and regulated quality standards.
Celerion’s Zürich laboratory is Swissmedic GLP-certified for preclinical and clinical sample analysis. This certification is accepted by other regulatory bodies throughout the OECD, as well as the FDA and Japan’s MHLW.